Gene expression profiling of sesaminol triglucoside and its tetrahydrofuranoid metabolites in primary rat hepatocytes

References

• Akimoto K, Kigawa Y, Akamatsu T, Hirose N, Sugano M, Shimizu S, Yamada H. 1993. Protective effect of sesamin against liver damage caused by alcohol or carbontetrachloride in rodents. Ann Nutr Metab 37:218–224
   PubMed Web of Science ®Google Scholar
• Ashakumary L, Rouyer IA, Takahashi Y, Ide T, Fukuda N, Aoyama T, Hashimoto T, et al. 1999. Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat. Metabolism 48:1303–1313
   PubMed Web of Science ®Google Scholar
• Garty H, Karlish SJ. 2006. Role of FXYD proteins in ion transport. Annu Rev Physiol 68:431–459
   PubMed Web of Science ®Google Scholar
• Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA. 2004. “The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins: introduction”. Pflugers Arch 447:465–468
   PubMed Web of Science ®Google Scholar
• Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wähälä K, Deyama T, Nishibe S, Adlercreutz H. 2001. In vitro metabolism of plant lignans: new precutsors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49:3178–3186
   PubMed Web of Science ®Google Scholar
• Huang M, Jin J, Sun H, Liu GT. 2008. Reversal of P-glykoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schisandrae. Cancer Chemother Pharmacol 62:1015–1026
   PubMed Web of Science ®Google Scholar
• Ide T, Lim JS, Odbayar TO, Nakashima Y. 2009a. Comparative study of sesame lignans (sesamin, episesamin and sesamolin) affecting gene expression profile and fatty acid oxidation in rat liver. J Nutr Sci Vitaminol 55:31–43
   PubMed Web of Science ®Google Scholar
• Ide T, Nakashima Y, Iida H, Yasumoto S, Katsuta M. 2009b. Lipid metabolism and nutrigenomics – impact of sesame lignans on gene expression profiles and fatty acid oxidation in rat liver. Forum Nutr 61:10–24
   PubMedGoogle Scholar
• Jan KC, Hwang LS, Ho CT. 2009a. Biotransformation of sesaminol triglucoside to mammalian lignans by intestinal microbiota. J Agric Food Chem 57:6101–6106
   PubMedGoogle Scholar
• Jan KC, Hwang LS, Ho CT. 2009b. Tissue distribution and elimination of sesaminol triglucoside and its metabolites in rat. Mol Nutr Food Res 53:815–825
   PubMedGoogle Scholar
• Jan KC, Ku KL, Chu YH, Hwang LS, Ho CT. 2011. Intestinal distribution and excretion of sesaminol and its tetrahydrofuranoid metabolites in rats. J Agric Food Chem 59:3078–3086
   PubMedGoogle Scholar
• Jan KC, Ku KL, Chu YH, Hwang LS, Ho CT. 2010. Tissue distribution and elimination of estrogenic and anti-inflammatory catechol metabolites fromsesaminol triglucoside in rats. J Agric Food Chem 58:7693–7700
   PubMedGoogle Scholar
• Kamal-Eldin A, Moazzami A, Washi S. 2011. Sesame seed lignans: potent physiological modulators and possible ingredients in functional foods & nutraceuticals. Recent Pat Food Nutr Agric 3:17–29
   PubMedGoogle Scholar
• Kuo JH, Jan MS, Lin YL, Lin C. 2009. Interactions between octaarginine and U–937 human macrophages: global gene expression profiling, superoxide anion content, and cytokine production. J Control Release 139:197–204
   PubMed Web of Science ®Google Scholar
• Lim YP, Ma CY, Liu CL, Lin YH, Hu ML, Chen JJ, Hung DZ, et al. 2012. Sesamin: a naturally occurring lignan inhibits CYP3A4 by antagonizing the pregnane X receptor activation. Evid Based Complement Alternat Med 2012:1--15
   Google Scholar
• Madgula VL, Avula B, Choi YW, Pullela SV, Khan IA, Walker LA, Khan SI. 2008. Transport of Schisandra chinensis extract and its biologically-active constituents across Caco-2 cell monolayers – an in vitro model of intestinal transport. J Pharm Pharmacol 60:363–370
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Tsuchie Y, Nakamura Y, Osawa T. 2009. Identification and characterization of sesaminol metabolites in the liver. J Agric Food Chem 57:10429–10434
   PubMedGoogle Scholar
• Okura T, Ibe M, Umegaki K, Shinozuka K, Yamada S. 2010. Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells. Biol Pharm Bull 33:255–259
   PubMed Web of Science ®Google Scholar
• Pan QR, Lu QH, Zhang K, Hu X. 2006. Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein. Cancer Chemother Pharmacol 58:99–106
   PubMed Web of Science ®Google Scholar
• Pan QR, Tao W, Lu QH, Hu X. 2005. Schisandrin B – a novel inhibitor of Pglycoprotein. Biochem Biophys Res Commun 335:406–411
   PubMedGoogle Scholar
• Peñalvo JL, Heinonen SM, Aura AM, Adlercreutz H. 2005. Dietary sesamin is converted to enterolactone in humans. J Nutr 135:1056–1062
   PubMed Web of Science ®Google Scholar
• Petzinger E, Geyer J. 2006. Drug transporters in pharmacokinetics. Naunyn–Schmiedeberg’s Arch Pharmacol 372:465–475
   Google Scholar
• Scheffer GL, Kool M, De Haas M, De Vree JM, Pijnenborg AC, Bosman DK, Oude Elferink R, et al. 2002. Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 82:193–201
   PubMed Web of Science ®Google Scholar
• Schlosser SF, Burgstahler AD, Nathanson MH. 1996. Isolated rat hepatocytes can signal to other hepatocytes and bile duct cells by release of nucleotides. Proc Natl Acad Sci USA 93:9948–9953
   PubMedGoogle Scholar
• Slaninová I, Brezinová L, Koubíková L, Slanina J. 2009. Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells-study of structure-activity relationship. Toxicol In Vitro 23:1047–1054
   PubMed Web of Science ®Google Scholar
• Sun M, Xu XL, Lu QH, Pan QR, Hu X. 2007. Schisandrin B: a dual inhibitor of Pglycoprotein and multidrug resistance-associated protein 1. Cancer Lett 246:300–307
   PubMedGoogle Scholar
• Tsuruoka N, Kidokoro A, Matsumoto I, Abe K, Kiso Y. 2005. Modulating effect of sesamin, a functional lignan in sesame seeds, on the transcription levels of lipid- and alcohol-metabolizing enzymes in rat liver: a DNA microarray study. Biosci Biotechnol Biochem 69:179–188
   PubMed Web of Science ®Google Scholar
• Wan CK, Zhu GY, Shen XL, Chattopadhyay, A, Dey, S, Fong WF. 2006. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells. Biochem Pharmacol 72:824–837
   PubMed Web of Science ®Google Scholar
• Webb AL, McCullough ML. 2005. Dietary lignans: potential role in cancer prevention. Nutr Cancer 51:117–131
   PubMed Web of Science ®Google Scholar
• Wróbel A, Eklund P, Bobrowska-Hägerstrand M, Hägerstrand H. 2010. Lignans and norlignans inhibit multidrug resistance protein 1 (MRP1/ABCC1)-mediated transport. Anticancer Res 30:4423–4428
   PubMedGoogle Scholar
• Yang S, Malaviya R, Wilson LJ, Argentieri R, Chen X, Yang C, Wang B, et al. 2007. Simplified staurosporine analogs as potent JAK3 inhibitors. Bioorg Med Chem Lett 17:326–331
   PubMed Web of Science ®Google Scholar
• Yang YM, Noh K, Han CY, Kim SG. 2010. Transactivation of genes encoding for phase II enzymes and phase III transporters by phytochemical antioxidants. Molecules 15:6332–6348
   PubMed Web of Science ®Google Scholar
• Yasuda K, Ikushiro S, Wakayama S, Itoh T, Yamamoto K, Kamakura M, Munetsuna E, et al. 2012. Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver. Drug Metab Dispos 40:1917–1926
   PubMed Web of Science ®Google Scholar
• Yasuda K, kushiro S, Kamakura M, Ohta M, Sakaki T. 2010. Metabolism of sesamin by cytochrome P450 in human liver microsomes. Drug Metab Dispos 8:2117–2123
   Google Scholar
• Zelcer N, van de Wetering K, Hillebrand M, Sarton E, Kuil A, Wielinga PR, Tephly T, et al. 2005. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl Acad Sci USA 102:7274–7279
   PubMed Web of Science ®Google Scholar